Gastric Cancer, 1436-3291

Journal

More filtering options
  1. 2021
  2. Crosstalk between WNT and STAT3 is mediated by galectin-3 in tumor progression

    Seok Jun Kim, Hyeok Gu Kang, Kyungeun Kim, Hoyoung Kim, Fredrik Zetterberg, Young Soo Park, Hyun Soo Cho, Stephen M. Hewitt, Joon Yong Chung, Ulf J. Nilsson, Hakon Leffler & Kyung Hee Chun, 2021, In: Gastric Cancer.

    Research output: Contribution to journalArticle

  3. 2019
  4. International consensus on a complications list after gastrectomy for cancer

    Gian Luca Baiocchi, Simone Giacopuzzi, Daniele Marrelli, Daniel Reim, Guillaume Piessen, Paulo Matos da Costa, John V. Reynolds, Hans Joachim Meyer, Paolo Morgagni, Ines Gockel, Lucio Lara Santos, Lone Susanne Jensen, Thomas Murphy, Shaun R. Preston, Mikhail Ter-Ovanesov, Uberto Fumagalli Romario, Maurizio Degiuli, Wojciech Kielan, Stefan Mönig, Piotr Kołodziejczyk & 16 others, Wojciech Polkowski, Richard Hardwick, Manuel Pera, Jan Johansson, Paul M. Schneider, Wobbe O. de Steur, Suzanne S. Gisbertz, Henk Hartgrink, Joanna W. van Sandick, Nazario Portolani, Arnulf H. Hölscher, Maristella Botticini, Franco Roviello, Christophe Mariette, William Allum & Giovanni de Manzoni, 2019 Jan, In: Gastric Cancer. 22, 1, p. 172-189

    Research output: Contribution to journalArticle

  5. 2012
  6. Does the risk of stomach cancer remain among second-generation immigrants in Sweden?

    Seyed Mohsen Mousavi, Kristina Sundquist & Kari Hemminki, 2012, In: Gastric Cancer. 15, 2, p. 213-215

    Research output: Contribution to journalArticle

  7. 2011
  8. 2010
  9. Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial

    Michael Gubanski, Anders Johnsson, Eva Fernebro, Lianna Kadar, Ingegerd Karlberg, Petra Flygare, Ake Berglund, Bengt Glimelius & Pehr A. Lind, 2010, In: Gastric Cancer. 13, 3, p. 155-161

    Research output: Contribution to journalArticle